PubHawk
J Biomed Sci April 2023 PMID 37101261

Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria.

He Liu, Zhen Hu, Mengyang Li, Yi Yang, Shuguang Lu, Xiancai Rao

Full text PDF Download social card

Mentions

3
Peak: 1 in Apr 2023
across 2 sources since Apr 2023

Extended reach

896
potential audience

Total likes

0

Video views

95

Mentions per month

Apr 2023 – Jul 2023

Where it's discussed

  • X / Twitter2 posts
  • YouTube1 videos

AI synopsis

What people are saying

The discussions highlight excitement about phages and endolysins, with comments like 'How exciting!' and references to their targeted bacterial action, showing strong interest and agreement. The tone and focus on potential medical breakthroughs reflect optimism about their impact, even if the discussion depth remains light.

AgreementModerate agreement

Most discussions express enthusiasm and agreement with the promising potential of bacteriophage endolysins as alternatives to antibiotics.

InterestHigh interest

The discussions show high interest, with phrases like 'How exciting!' and use of hashtags emphasizing relevance to antibiotic resistance.

EngagementModerate engagement

While the posts are brief, they reference key concepts like bacterial destruction and the therapeutic potential, indicating moderate engagement.

ImpactModerate impact

The posts hint at the significance of these findings for future medical treatments, suggesting a moderate perceived impact.

Abstract in brief

  • Bacteriophage endolysins are enzymes that can specifically target and break down the cell walls of Gram-positive bacteria, offering a promising alternative to traditional antibiotics, especially against resistant strains like MRSA.
  • Endolysins have low resistance development, making them effective candidates for antibacterial drugs, and their structural characteristics, mechanisms of action, and safety issues are actively being studied to improve their therapeutic use.
  • Despite some limitations, ongoing research and development suggest that endolysin-based therapies are likely to gain approval soon, providing a new approach to combat bacterial infections and addressing the challenges of antibiotic resistance.]
Read the full abstract

Top posts

Most liked on X and Bluesky
Phage Papers
@Phage_Papers · X

Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria https://t.co/rjSFbMpKED

Apr 27, 2023 · 647 followers View post →
“I don’t want to believe, I want to know” (Sagan)
@Int0Th1nA1r · X

How exciting! Phages= harmless #viruses that target specific #bacteria. Upon bacterial cell infection, they use #endolysins to destroy the bacterial cell-wall from within (…) https://t.co/UYV5La5cJ8 #AntibioticResistance #AMR #AntimicrobialResistance #Biomedicine #MedTwitter

Jun 3, 2023 · 155 followers View post →

All mentions

“I don’t want to believe, I want to know” (Sagan)
@Int0Th1nA1r · X

How exciting! Phages= harmless #viruses that target specific #bacteria. Upon bacterial cell infection, they use #endolysins to destroy the bacterial cell-wall from within (…) https://t.co/UYV5La5cJ8 #AntibioticResistance #AMR #AntimicrobialResistance #Biomedicine #MedTwitter

Jun 3, 2023 · 155 followers View post →
Phage Papers
@Phage_Papers · X

Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria https://t.co/rjSFbMpKED

Apr 27, 2023 · 647 followers View post →